BNP Paribas Financial Markets’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $386 | Hold |
50
| – | – | ﹤0.01% | 4424 |
|
|
2025
Q1 | $297 | Sell |
50
-11
| -18% | -$65 | ﹤0.01% | 4344 |
|
|
2024
Q4 | $812 | Buy |
61
+5
| +9% | +$67 | ﹤0.01% | 4258 |
|
|
2024
Q3 | $455 | Sell |
56
-36,668
| -100% | -$298K | ﹤0.01% | 3281 |
|
|
2024
Q2 | $312K | Buy |
36,724
+21,401
| +140% | +$182K | ﹤0.01% | 2241 |
|
|
2024
Q1 | $266K | Buy |
15,323
+3,473
| +29% | +$60.3K | ﹤0.01% | 2497 |
|
|
2023
Q4 | $152K | Buy |
11,850
+11,061
| +1,402% | +$142K | ﹤0.01% | 2589 |
|
|
2023
Q3 | $29.2K | Sell |
789
-2,237
| -74% | -$82.7K | ﹤0.01% | 2851 |
|
|
2023
Q2 | $122K | Sell |
3,026
-7,290
| -71% | -$293K | ﹤0.01% | 2584 |
|
|
2023
Q1 | $748K | Buy |
10,316
+6,030
| +141% | +$437K | ﹤0.01% | 1926 |
|
|
2022
Q4 | $351K | Sell |
4,286
-3,645
| -46% | -$299K | ﹤0.01% | 2136 |
|
|
2022
Q3 | $749K | Buy |
7,931
+6,856
| +638% | +$648K | ﹤0.01% | 2061 |
|
|
2022
Q2 | $209K | Buy |
1,075
+541
| +101% | +$105K | ﹤0.01% | 2442 |
|
|
2022
Q1 | $124K | Sell |
534
-1,434
| -73% | -$333K | ﹤0.01% | 2738 |
|
|
2021
Q4 | $775K | Buy |
1,968
+804
| +69% | +$317K | ﹤0.01% | 2179 |
|
|
2021
Q3 | $521K | Buy |
1,164
+317
| +37% | +$142K | ﹤0.01% | 2166 |
|
|
2021
Q2 | $329K | Sell |
847
-595
| -41% | -$231K | ﹤0.01% | 2147 |
|
|
2021
Q1 | $518K | Sell |
1,442
-2,808
| -66% | -$1.01M | ﹤0.01% | 2026 |
|
|
2020
Q4 | $2.09M | Buy |
4,250
+3,565
| +520% | +$1.75M | ﹤0.01% | 1124 |
|
|
2020
Q3 | $222K | Buy |
685
+368
| +116% | +$119K | ﹤0.01% | 2120 |
|
|
2020
Q2 | $115K | Sell |
317
-785
| -71% | -$286K | ﹤0.01% | 2100 |
|
|
2020
Q1 | $234K | Buy |
1,102
+846
| +330% | +$180K | ﹤0.01% | 2198 |
|
|
2019
Q4 | $105K | Sell |
256
-64
| -20% | -$26.4K | ﹤0.01% | 2615 |
|
|
2019
Q3 | $113K | Buy |
320
+118
| +58% | +$41.7K | ﹤0.01% | 2441 |
|
|
2019
Q2 | $102K | Sell |
202
-163
| -45% | -$81.9K | ﹤0.01% | 2423 |
|
|
2019
Q1 | $362K | Buy |
365
+350
| +2,333% | +$347K | ﹤0.01% | 1760 |
|
|
2018
Q4 | $12.9K | Sell |
15
-52
| -78% | -$44.8K | ﹤0.01% | 2590 |
|
|
2018
Q3 | $69.2K | Buy |
67
+4
| +6% | +$4.13K | ﹤0.01% | 2270 |
|
|
2018
Q2 | $58K | Sell |
63
-208
| -77% | -$192K | ﹤0.01% | 2418 |
|
|
2018
Q1 | $264K | Buy |
271
+43
| +19% | +$41.9K | ﹤0.01% | 2094 |
|
|
2017
Q4 | $103K | Buy |
228
+130
| +133% | +$58.9K | ﹤0.01% | 2630 |
|
|
2017
Q3 | $40.4K | Sell |
98
-6
| -6% | -$2.47K | ﹤0.01% | 2785 |
|
|
2017
Q2 | $36.4K | Buy |
104
+99
| +1,980% | +$34.7K | ﹤0.01% | 2853 |
|
|
2017
Q1 | $2.71K | Sell |
5
-47
| -90% | -$25.5K | ﹤0.01% | 2895 |
|
|
2016
Q4 | $18.5K | Sell |
52
-12
| -19% | -$4.27K | ﹤0.01% | 2702 |
|
|
2016
Q3 | $34.4K | Buy |
64
+27
| +73% | +$14.5K | ﹤0.01% | 2606 |
|
|
2016
Q2 | $21.1K | Buy |
+37
| New | +$21.1K | ﹤0.01% | 2567 |
|
|
2016
Q1 | – | Sell |
-155
| Closed | -$103K | – | 2693 |
|
|
2015
Q4 | $103K | Buy |
155
+14
| +10% | +$9.27K | ﹤0.01% | 2319 |
|
|
2015
Q3 | $111K | Buy |
141
+93
| +194% | +$73.2K | ﹤0.01% | 2329 |
|
|
2015
Q2 | $63.6K | Buy |
48
+42
| +700% | +$55.6K | ﹤0.01% | 2344 |
|
|
2015
Q1 | $6.69K | Buy |
+6
| New | +$6.69K | ﹤0.01% | 2984 |
|